Are Quality Excellence and Quality Metrics Top of your Agenda for 2018?

Then don't miss the Operational Excellence & Quality Metrics Conference on January 31 at the Dublin Institute of Technology.

As the leading research institution in the field of Operational Excellence (OPEX) in the pharmaceutical industry, St. Gallen University has been conducting research in this field, as well as undertaking many practical industry OPEX projects, for more than 13 years. In collaboration with DIT, there will be a special focus this year on the key findings from our recent Operational Excellence and Quality Metrics Research, financed by the US FDA. Furthermore, a copy of the FDA Quality Metrics Research Report will be made available to all delegates.

The conference led by Prof. Dr. Thomas Friedli and Dr. Nuala Calnan (DIT) is the ideal place to get first-hand insights on current global challenges in the pharmaceutical industry that can affect your organisation's ability to achieve quality excellence. The day will include a mix of presentation on quality excellence research findings, industry benchmarking, OPEX projects and several interactive workshop sessions to allow you to be part of a fruitful discussion.

At this Dublin conference we will also provide you with insights from the ongoing St.Gallen OPEX Benchmarking activities in manufacturing and quality control labs. Further details on both benchmarking opportunities can be found on our website: https://tectem.ch/institute/opex/benchmarking or https://tectem.ch/institute/opex/qclab-benchmarking

You can select between conference only price or combine the attendance at the conference with benchmarking your organisation's performance. As a new feature please also consider the new partnership opportunities we have with PDA's Quality Culture activities. Please follow the link to register: https://tectem.ch/institute/opex/conference